Literature DB >> 20537764

[Population-based cross sectional study about vaccine acceptability and perception of the severity of A/H1N1 influenza: opinion of the general population and health professionals].

Antxon Apiñaniz1, Amanda López-Picado, Erika Miranda-Serrano, Amaia Latorre, Raquel Cobos, Naiara Parraza-Díez, Patricia Amezua, Mónica Martínez-Cengotitabengoa, Felipe Aizpuru.   

Abstract

OBJECTIVES: To determine the intention of general population and health professionals to vaccinate against the H1N1 influenza A virus. To determine the perception of severity of the H1N1 influenza A in both groups compared to that of seasonal influenza.
METHODS: Cross-sectional telephone survey performed to a sample of population (obtained randomly from the Vitoria-Gasteiz telephone directory) and cross-sectional electronically-administered survey to a sample of health professionals from public health centres in Vitoria-Gasteiz, conducted between 6th and 16th November 2009. The relative and absolute frecuency of persons willing to be vaccinated and the proportion of those considering the H1N1 influenza A as a life-threatening risk were calculated in both groups.
RESULTS: 219 (33%) persons out of 637 contacted telephone numbers answered the questionnaire, as well as 109 health professionals. 63.0% (n=138) of general population and 73.4% (n=80) of the professional group would not undergo vaccination, even if it was for free (p=0.595). If belonging to a high-risk group, the corresponding proportions of unwillingness were 14.6% (n=32) for general population and 40.4 (n=44) for professionals (p<0.001). The proportion of undecided persons is 25.6% (n=56) in general population, against 6.4% (n=7) among the professionals.
CONCLUSIONS: At the beginning of the vaccination campaign, the majority of population is unwilling to undergo immunization against the H1N1 influenza A virus. The proportion in general population is similar to that among the health professionals. However, when belonging to a high-risk group, there is a high proportion of undecided persons in general population.
Copyright © 2009 SESPAS. Published by Elsevier Espana. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20537764     DOI: 10.1016/j.gaceta.2010.03.009

Source DB:  PubMed          Journal:  Gac Sanit        ISSN: 0213-9111            Impact factor:   2.139


  5 in total

1.  Knowledge about COVID-19 and vaccine acceptability among priority groups defined for vaccination: A cross-sectional study in Araba/Alava, Spain, before the vaccination against SARS-CoV-2.

Authors:  Naiara Parraza-Diez; Cristina Bermudez-Ampudia; Raquel Cobos-Campos; Ines Garmendia; Estibalitz Orruño; Elena Ojeda; Ignacio Garitano; María Robledo; Jose Joaquín Portu; Antxon Apiñaniz
Journal:  Vaccine X       Date:  2022-06-06

2.  Knowledge, attitudes and perceptions of health professionals in relation to A/H1N1 influenza and its vaccine.

Authors:  Amanda López-Picado; Antxon Apiñaniz; Amaia Latorre Ramos; Erika Miranda-Serrano; Raquel Cobos; Naiara Parraza-Díez; Patricia Amezua; Mónica Martinez-Cengotitabengoa; Felipe Aizpuru
Journal:  Emerg Health Threats J       Date:  2012-01-11

3.  Motivation for Vaccination against COVID-19 in Persons Aged between 18 and 60 Years at a Population-Based Vaccination Site in Manresa (Spain).

Authors:  Glòria Sauch Valmaña; Aïna Fuster-Casanovas; Anna Ramírez-Morros; Berta Rodoreda Pallàs; Josep Vidal-Alaball; Anna Ruiz-Comellas; Queralt Miró Catalina
Journal:  Vaccines (Basel)       Date:  2022-04-12

4.  Influenza vaccination in coronavirus times: Primary Care professionals' intention to get vaccinated in Central Catalonia (VAGCOVID). A cross sectional study.

Authors:  Raquel Muñoz-Miralles; Anna Bonet-Esteve; Anna Rufas-Cebollero; Aïna Fuster-Casanovas; Xavier Pelegrin-Cruz; Josep Vidal-Alaball
Journal:  Hum Vaccin Immunother       Date:  2022-07-01       Impact factor: 4.526

5.  Influenza vaccination during the coronavirus pandemic: intention to vaccinate among the at-risk population in the Central Catalonia Health Region (VAGCOVID).

Authors:  Anna Bonet-Esteve; Raquel Muñoz-Miralles; Carla Gonzalez-Claramunt; Ana M Rufas; Xavier Pelegrin Cruz; Josep Vidal-Alaball
Journal:  BMC Fam Pract       Date:  2021-05-01       Impact factor: 2.497

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.